Our first edition of 2022 focuses on Healthcare and Life Sciences. It is a sector that will once again have the spotlight on it this year as we continue to tackle COVID-19 and its subsequent variants. While the pandemic continues to challenge the sector, governments across the region forge ahead with their plans to expand and upgrade healthcare systems and develop robust world-class healthcare infrastructure.
For the region, healthcare is a vital pillar in diversifying its economies, both locally and as medical tourism hubs. To underpin this, healthcare authorities across the region continue to implement frameworks and regulations that provide structure and accountability.
In this edition, you have unique access to great insights and expert commentary on a number of pertinent healthcare regulatory developments. You will find a topical mix of articles; for example, our lawyers discuss vaccines and returning to work during the pandemic. They take you through several other areas, including stem cell research in Bahrain, clinical research laws in Egypt, and Saudi medical device and pharmaceutical laws.Take a read of the edition
Al Tamimi & Company opened its first Saudi Arabian office, in the capital Riyadh, in 2008.
The largest city in Saudi Arabia, Riyadh is home to the majority of Saudi ministries and Government departments, hence why Al Tamimi’s Riyadh office remains the firm’s operational ‘headquarters’ in the Kingdom. This allows us to engage daily with the Saudi Courts and key Saudi regulators, so that we are best placed to keep on top of changes in laws, regulations and administrative oversight.
Lawyers from our Riyadh office work closely with colleagues in our Jeddah and Al Khobar offices, servicing clients from around the Kingdom, with support from Al Tamimi & Company’s network of 17 offices across the MENA region.Contact us